AN UNBIASED VIEW OF AROMASIN

AROMASIN is indicated for adjuvant treatment of postmenopausal Women of all ages with estrogen-receptor positive early breast most cancers who have been given two to three a long time of tamoxifen and so are switched to AROMASIN for completion of a complete of five consecutive years of adjuvant hormonal therapy [see Clinical Reports (fourteen.one)]